← Back to headlines
Kymera, Monte Rosa Stocks Rise Following Novartis Molecular Glue Drug Deal
Shares of Kymera and Monte Rosa Therapeutics saw gains after Novartis announced a deal for molecular glue drugs, impacting the pharmaceutical sector.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
